Molecular Cancer Therapeutics CTRC-AACR San Antonio Breast Cancer Symposium Bridging the Lab and the Clinic in Cancer Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, S. S.
Right arrow Articles by Ngan, H. Y.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, S. S.
Right arrow Articles by Ngan, H. Y.-S.
Mol Cancer Ther. 2006;5:1209-1215
© 2006 American Association for Cancer Research

Research Articles: Therapeutics

Enhancement of the radiosensitivity of cervical cancer cells by overexpressing p73{alpha}

Stephanie Si Liu1, Kelvin Yuen-Kwong Chan1,2, Rebecca Ching-Yu Leung1, Helen Ka-Wai Law3, Tsin-Wah Leung1 and Hextan Yuen-Sheung Ngan1

Departments of 1 Obstetrics and Gynaecology, 2 Pathology, and 3 Paediatrics and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China

Requests for reprints: Hextan Yuen-Sheung Ngan, Department of Obstetrics and Gynaecology, Queen Mary Hospital, 6th Floor, Professorial Block, Pokfulam Road, Hong Kong SAR, China. Phone: 852-28554684; Fax: 852-28550947. E-mail: hysngan{at}hkucc.hku.hk

Radiation therapy is the most effective therapy for cervical cancer in advanced stages. p53 plays a critical role in the cellular response to radiation-induced DNA damage. However, p53 function is often impaired in the presence of the oncoprotein E6 from human papillomavirus, which is often associated with the development of cervical cancer. p73, a p53 family member, is highly similar to p53, but is resistant to the degradation by human papillomavirus E6. In this study, we investigated the role of p73{alpha} in relation to cellular radiosensitivity in the p53-impaired cervical cancer cells. Radiosensitivity and irradiation-induced apoptotic cell death were examined in the exogenous overexpressed p73{alpha}- and p53-impaired cells. Our results showed that the endogenous p73{alpha} expressed only in the radiosensitive cervical cancer C4-1 cells, but not in the radioresistant SiHa, Caski, and HeLa cells. Overexpression of exogenous p73{alpha} by transfection in the radioresistant cells resulted in a significant increase of cellular sensitivity to radiation. Enhanced radiosensitivity in p73{alpha}-transfected cells was attributed by increase of cellular apoptosis. Coactivation of p21 was also observed in the p73{alpha}-transfected cells upon radiation treatment. In summary, our findings suggested that p73{alpha} is an important determinant of cellular radiosensitivity in the p53-impaired cervical cancer cells. [Mol Cancer Ther 2006;5(5):1209–15]


Grant support: Research Grant Council of the Hong Kong Special Administrative Region, China (HKU 7441/03M).

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 11/ 1/05; revised 2/21/06; accepted 3/15/06.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
Y. Ma, W.-D. Yu, P. A. Hershberger, G. Flynn, R.-X. Kong, D. L. Trump, and C. S. Johnson
1{alpha},25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model
Mol. Cancer Ther., September 1, 2008; 7(9): 3047 - 3055.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.